Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine versus placebo in obsessive-compulsive disorder
NL-OMON32677Phase 3Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Memantine with Placebo (2 arms). Primary endpoints: Change in Yale-Brown Obsessive-Compulsive Scale from baseline to week 12 and Responder rate. Planned start Apr 2010; status: withdrawn.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON32677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32677.